INCOG BioPharma Services has filed a notice of an exempt offering of securities to raise $42,864,002.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, INCOG BioPharma Services is raising up to $42,864,002.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Cory Lewis played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About INCOG BioPharma Services
At INCOG BioPharma Services our services will include injectable drug product formulation development, analytical method development, process scale up, and formulation & filling of vials, syringes and cartridges. In addition, we will offer customized packaging services to include labeling, device assembly, final packaging and integrated storage solutions at various temperature conditions.
To learn more about INCOG BioPharma Services, visit http://www.incogbiopharma.com/
Contact:
Cory Lewis, Chief Executive Officer
812-322-0201
https://www.linkedin.com/in/cory-lewis-2a04b51/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.